Qingdao, China

Jiang Tao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Mcgill University, Ocean University of China. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiang Tao. Retrieved from https://idiyas.com/inventor/jiang-tao-pqkbavji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiang Tao: Innovator in Pharmaceutical Compounds

Introduction

Jiang Tao is a notable inventor based in Qingdao, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cell invasion protein complexes. His work is crucial for advancing treatments for metastatic diseases.

Latest Patents

Jiang Tao holds 1 patent for his invention titled "Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof." This patent relates to compounds that inhibit key proteins such as AKT-1, FAK, and PKCα, which are vital in the treatment and prevention of metastatic diseases.

Career Highlights

Throughout his career, Jiang Tao has been associated with prestigious institutions, including Ocean University of China and McGill University. His work at these universities has allowed him to engage in cutting-edge research and innovation in the pharmaceutical field.

Collaborations

Jiang has collaborated with notable colleagues, including Moulay Alaoui-Jamali and Krikor Bijian. These partnerships have further enriched his research and contributed to the advancement of his inventions.

Conclusion

Jiang Tao's innovative work in pharmaceutical compounds demonstrates his commitment to improving medical treatments for serious diseases. His contributions are invaluable to the scientific community and the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…